$GGB

Metz Mauricio sold $34K of GGB

Metz Mauricio sold 7,000 shares of GERDAU S.A. (GGB) at $4.85 on 2026-06-02.

Original reporting
SEC EDGAR · Metz Mauricio
Published Jun 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GGB
Neutral
low confidence
Mentioned
$GGB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GGBNeutralLow
01

Why it matters

The only new fact is the reported open-market sale of 7,000 shares by Metz Mauricio at $4.85/share, with holdings after the sale of 22,536 shares.

02

Market read

This is a routine insider sale disclosure with limited trading implications absent additional company-specific catalysts.

03

What to watch

The article lacks context on total holdings, compensation structure, tax events, and whether other insiders filed concurrent transactions.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-03, transaction dated 2026-06-02.

Background

The article is an SEC Form 4 insider transaction disclosure for Gerdau S.A. (GGB).

Company-level read

Ticker impact

$GGBNeutralLow confidence
Context

SEC Form 4 shows Metz Mauricio sold 7,000 shares of Gerdau (GGB) on 2026-06-02 for about $33,950 total.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

The filing is a routine insider transaction with no accompanying guidance, operational change, or enforcement action. The article provides sale size and price but no new business information.

Market effects

No sector read-through is provided beyond a single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales are often planned for liquidity or diversification; without a 10b5-1 plan, the sale still may be non-informational.

Key entities

  • GERDAU S.A.

    Subject of the Form 4 insider transaction disclosure (GGB).

  • Metz Mauricio

    Reporter of the Form 4 transaction; sold 7,000 shares on 2026-06-02.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GGBMed

Gerdau (GGB) Q3 2026 Earnings Call Transcript

Gerdau S.A. reported Q3 2026 earnings, highlighting BRL 1.7B free cash flow, BRL 0.34/share dividends, and a solid balance sheet. The company expects to return over BRL 1.85B to shareholders in 2026. North American operations showed strong demand, while Brazil faced seasonal slowdowns and import challenges. The company plans adjustments to improve Brazilian profitability and is awaiting government support on trade and energy policies.

$GGBMed

What Gerdau (GGB) Said on Its Q3 Earnings Call

Gerdau (GGB) is expanding capacity at its Texas facility, with full production expected by 2027. The company focuses on organic investments, not spin-offs or major acquisitions. Management discussed potential trade impacts on regional margins. In Brazil, Gerdau faces import pressure but plans productivity improvements. The company announced dividends and reduced capital expenditure plans to BRL 4 billion. Net debt to EBITDA is 0.58 times, with a positive outlook from S&P.

$GGBMedAI 8/10

Gerdau ADR earnings missed, revenue topped estimates

Gerdau ADR (GGB) reported Q3 EPS of $0.159, missing estimates of $0.165, while revenue of $3.75B exceeded expectations. The stock is down 4.23% over 3 months but up 37.28% year-over-year. Analysts revised EPS positively twice in the last 90 days. InvestingPro rates its financial health as good.